Home » Topics » Conferences

Conferences
RSS

SKB describes potent, selective IL-8beta receptor antagonists

April 29, 1997

Potent and selective iNOS inhibitor disclosed by Merck & Co.

April 29, 1997

DuPont Merck describes potent, orally bioavailable cyclic urea HIV protease inhibitor

April 29, 1997

PD-170262: potent and selective PDGF TK inhibitor from Parke-Davis

April 29, 1997

Pharmacia & Upjohn prepares potent and selective dopamine D4 antagonist

April 29, 1997

Pharmacokinetic data for pentafuside in rodents, monkeys and man

April 29, 1997

RPR describes novel farnesyltransferase inhibitors

April 28, 1997

Parke-Davis SAR studies lead to potent, selective D4 antagonist

April 28, 1997

Potent TNF inhibitor described by Celgene

April 28, 1997

Potential new treatments highlighted at recent periodontology symposium

April 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...